Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.
Nat Commun.
2020 Sep 14;11(1):4591. doi: 10.1038/s41467-020-18245-7. PubMed PMID:
32929084; PubMed Central PMCID:
PMC7490264.
Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy.
iScience.
2020 Jun 26;23(6):101215. doi: 10.1016/j.isci.2020.101215. Epub 2020 May 30. Review. PubMed PMID:
32512383; PubMed Central PMCID:
PMC7260547.
Rab25-Mediated EGFR Recycling Causes Tumor Acquired Radioresistance.
iScience.
2020 Apr 24;23(4):100997. doi: 10.1016/j.isci.2020.100997. Epub 2020 Mar 20. PubMed PMID:
32252020; PubMed Central PMCID:
PMC7132159.
Cell repopulation, rewiring metabolism, and immune regulation in cancer radiotherapy.
Radiation Medicine and Protection. 2020 March; doi: doi.org/10.1016/j.radmp.2020.02.001.
Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo.
Nat Nanotechnol.
2020 Feb;15(2):145-153. doi: 10.1038/s41565-019-0626-4. Epub 2020 Jan 27. PubMed PMID:
31988501; PubMed Central PMCID:
PMC7147967.
Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade.
Dev Cell.
2020 Jan 27;52(2):196-209.e9. doi: 10.1016/j.devcel.2019.11.012. Epub 2019 Dec 19. PubMed PMID:
31866205; PubMed Central PMCID:
PMC6996588.
Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.
Oncol Rep.
2020 Jan;43(1):318-327. doi: 10.3892/or.2019.7418. Epub 2019 Nov 27. PubMed PMID:
31789405; NIHMSID:NIHMS1627704.
Multiple Dynamics in Tumor Microenvironment Under Radiotherapy.
Adv Exp Med Biol.
2020;1263:175-202. doi: 10.1007/978-3-030-44518-8_10. Review. PubMed PMID:
32588328.
CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer.
Front Oncol.
2019;9:1201. doi: 10.3389/fonc.2019.01201. eCollection 2019. PubMed PMID:
31803610; PubMed Central PMCID:
PMC6873486.
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype.
Nat Commun.
2019 Oct 11;10(1):4621. doi: 10.1038/s41467-019-12529-3. PubMed PMID:
31604910; PubMed Central PMCID:
PMC6789042.
Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
Redox Biol.
2019 Jun;24:101189. doi: 10.1016/j.redox.2019.101189. Epub 2019 Apr 9. PubMed PMID:
30986607; PubMed Central PMCID:
PMC6463934.
Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
Cancer Res.
2019 May 15;79(10):2697-2708. doi: 10.1158/0008-5472.CAN-18-3125. Epub 2019 Mar 21. PubMed PMID:
30898840; NIHMSID:NIHMS1525388.
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance.
Cancer Lett.
2019 Feb 28;443:56-66. doi: 10.1016/j.canlet.2018.11.019. Epub 2018 Nov 24. Review. PubMed PMID:
30481564; PubMed Central PMCID:
PMC6759061.
Targeted Profiling of Heat Shock Proteome in Radioresistant Breast Cancer Cells.
Chem Res Toxicol.
2019 Feb 18;32(2):326-332. doi: 10.1021/acs.chemrestox.8b00330. Epub 2019 Jan 11. PubMed PMID:
30596229; PubMed Central PMCID:
PMC6469359.
Immune targets in the tumor microenvironment treated by radiotherapy.
Theranostics.
2019;9(5):1215-1231. doi: 10.7150/thno.32648. eCollection 2019. Review. PubMed PMID:
30867826; PubMed Central PMCID:
PMC6401500.
Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.
Nano Lett.
2018 Nov 14;18(11):7092-7103. doi: 10.1021/acs.nanolett.8b03096. Epub 2018 Oct 26. PubMed PMID:
30339018; PubMed Central PMCID:
PMC6501589.
Nanoparticles for live cell microscopy: A surface-enhanced Raman scattering perspective.
Sci Rep.
2017 Jun 30;7(1):4471. doi: 10.1038/s41598-017-04066-0. PubMed PMID:
28667313; PubMed Central PMCID:
PMC5493633.
Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.
Free Radic Biol Med.
2016 Oct;99:110-119. doi: 10.1016/j.freeradbiomed.2016.07.009. Epub 2016 Jul 15. PubMed PMID:
27427516; PubMed Central PMCID:
PMC6764831.
Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Cancer Lett.
2016 Aug 10;378(2):69-79. doi: 10.1016/j.canlet.2016.05.004. Epub 2016 May 6. PubMed PMID:
27164560; PubMed Central PMCID:
PMC7505026.
All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.
BMC Complement Altern Med.
2016 Mar 31;16:113. doi: 10.1186/s12906-016-1088-y. PubMed PMID:
27036550; PubMed Central PMCID:
PMC4815257.
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1.
J Vis Exp.
2016 Feb 25;(108):53417. doi: 10.3791/53417. PubMed PMID:
26967001; PubMed Central PMCID:
PMC4828183.
CDK1 Enhances Mitochondrial Bioenergetics for Radiation-Induced DNA Repair.
Cell Rep.
2015 Dec 15;13(10):2056-63. doi: 10.1016/j.celrep.2015.11.015. Epub 2015 Dec 6. PubMed PMID:
26670043; PubMed Central PMCID:
PMC4684969.
Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides.
Cancer Lett.
2015 Dec 1;369(1):112-23. doi: 10.1016/j.canlet.2015.08.002. Epub 2015 Aug 21. PubMed PMID:
26304717.
The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
J Cancer Res Clin Oncol.
2015 Oct;141(10):1697-713. doi: 10.1007/s00432-014-1840-y. Epub 2014 Oct 1. Review. PubMed PMID:
25270087; PubMed Central PMCID:
PMC4382462.
MKP1 mediates resistance to therapy in HER2-positive breast tumors.
Mol Cell Oncol.
2015 Oct-Dec;2(4):e997518. doi: 10.1080/23723556.2014.997518. eCollection 2015 Oct-Dec. PubMed PMID:
27308517; PubMed Central PMCID:
PMC4905363.
CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance.
Mol Cancer Ther.
2015 Sep;14(9):2090-102. doi: 10.1158/1535-7163.MCT-15-0017. Epub 2015 Jul 3. PubMed PMID:
26141949; PubMed Central PMCID:
PMC4560959.
SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells.
PLoS One.
2015;10(6):e0129834. doi: 10.1371/journal.pone.0129834. eCollection 2015. PubMed PMID:
26121691; PubMed Central PMCID:
PMC4487898.
CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection.
Free Radic Biol Med.
2015 Apr;81:77-87. doi: 10.1016/j.freeradbiomed.2014.12.026. Epub 2015 Jan 8. PubMed PMID:
25578653; PubMed Central PMCID:
PMC4359946.
NFκB and Survivin-Mediated Radio-Adaptive Response.
Radiat Res.
2015 Apr;183(4):391-7. doi: 10.1667/RR14002.1. Epub 2015 Mar 12. PubMed PMID:
25763931.
Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
PLoS One.
2015;10(3):e0121046. doi: 10.1371/journal.pone.0121046. eCollection 2015. PubMed PMID:
25807077; PubMed Central PMCID:
PMC4373728.
Anthropomorphic Phantoms for Confirmation of Linear Accelerator-Based Small Animal Irradiation.
Cureus.
2015 Mar;7(3):e254. doi: 10.7759/cureus.254. eCollection 2015 Mar. PubMed PMID:
26180678; PubMed Central PMCID:
PMC4494576.
Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics.
J Proteome Res.
2015 Jan 2;14(1):193-201. doi: 10.1021/pr500919w. Epub 2014 Nov 4. PubMed PMID:
25341124; PubMed Central PMCID:
PMC4286165.
Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells.
Cancer Res.
2014 Dec 15;74(24):7498-509. doi: 10.1158/0008-5472.CAN-14-0844. Epub 2014 Nov 6. PubMed PMID:
25377473; PubMed Central PMCID:
PMC4267894.
Breast cancer stem cells: Multiple capacities in tumor metastasis.
Cancer Lett.
2014 Jul 10;349(1):1-7. doi: 10.1016/j.canlet.2014.03.036. Epub 2014 Apr 12. Review. PubMed PMID:
24727284; PubMed Central PMCID:
PMC4177877.
Blocking the formation of radiation-induced breast cancer stem cells.
Oncotarget.
2014 Jun 15;5(11):3743-55. doi: 10.18632/oncotarget.1992. PubMed PMID:
25003837; PubMed Central PMCID:
PMC4116517.
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.
Dev Cell.
2014 Apr 28;29(2):217-32. doi: 10.1016/j.devcel.2014.03.012. Epub 2014 Apr 17. PubMed PMID:
24746669; PubMed Central PMCID:
PMC4156313.
Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
PLoS One.
2014;9(4):e93886. doi: 10.1371/journal.pone.0093886. eCollection 2014. PubMed PMID:
24699863; PubMed Central PMCID:
PMC3974849.
Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.
Mol Cancer Res.
2014 Apr;12(4):539-49. doi: 10.1158/1541-7786.MCR-13-0459. Epub 2014 Jan 3. PubMed PMID:
24391143; PubMed Central PMCID:
PMC4139106.
MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.
Antioxid Redox Signal.
2014 Apr 1;20(10):1599-617. doi: 10.1089/ars.2013.5305. Epub 2013 Jun 8. Review. PubMed PMID:
23581847; PubMed Central PMCID:
PMC3942709.
Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response.
Antioxid Redox Signal.
2014 Mar 20;20(9):1463-80. doi: 10.1089/ars.2013.5684. Epub 2014 Feb 14. Review. PubMed PMID:
24180340; PubMed Central PMCID:
PMC3936506.
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.
J Cancer Res Clin Oncol.
2014 Jan;140(1):1-14. doi: 10.1007/s00432-013-1494-1. Epub 2013 Aug 30. Review. PubMed PMID:
23990015; PubMed Central PMCID:
PMC3889683.
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Adv Cancer Res.
2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1. Review. PubMed PMID:
25081533; PubMed Central PMCID:
PMC6759082.
Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II.
Breast Cancer (Dove Med Press).
2013;5:87-101. doi: 10.2147/BCTT.S51378. eCollection 2013. PubMed PMID:
24648762; PubMed Central PMCID:
PMC3929248.
Molecular mechanisms and treatment of radiation-induced lung fibrosis.
Curr Drug Targets.
2013 Oct;14(11):1347-56. doi: 10.2174/13894501113149990198. Review. PubMed PMID:
23909719; PubMed Central PMCID:
PMC4156316.
A survivin-associated adaptive response in radiation therapy.
Cancer Res.
2013 Jul 15;73(14):4418-28. doi: 10.1158/0008-5472.CAN-12-4640. Epub 2013 May 7. PubMed PMID:
23651635; PubMed Central PMCID:
PMC3721325.
Comparing radiation toxicities across species: an examination of radiation effects in Mus musculus and Peromyscus leucopus.
Int J Radiat Biol.
2013 Jun;89(6):391-400. doi: 10.3109/09553002.2013.767994. Epub 2013 Mar 4. PubMed PMID:
23362954.
CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress.
J Mol Cell Biol.
2013 Jun;5(3):166-75. doi: 10.1093/jmcb/mjs062. Epub 2012 Dec 12. PubMed PMID:
23243068; PubMed Central PMCID:
PMC3656610.
The dynamic change of CD47 expression promotes tumor burden, metastases and resistance of breast cancer cells to radiotherapy.
Cancer Research. 2013 April; 73:4963. doi: 10.1158/1538-7445.AM2013-4963.
A manganese superoxide dismutase (SOD2)-mediated adaptive response.
Radiat Res.
2013 Feb;179(2):115-24. doi: 10.1667/RR3126.2. Epub 2012 Dec 13. PubMed PMID:
23237540; PubMed Central PMCID:
PMC3594688.
The role of radiotherapy-resistant stem cells in breast cancer recurrence.
Breast Cancer Manag.
2013;2(2):89-92. doi: 10.2217/bmt.13.5. PubMed PMID:
25598844; PubMed Central PMCID:
PMC4295787.
What would you like to do?